Satsuma Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STSA and other ETFs, options, and stocks.

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. 

CEO
John A. Kollins
CEOJohn A. Kollins
Employees
21
Employees21
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2016
Founded2016
Employees
21
Employees21

STSA Key Statistics

Market cap
166.47M
Market cap166.47M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
183.28K
Average volume183.28K
High today
$6.17
High today$6.17
Low today
$5.02
Low today$5.02
Open price
$5.90
Open price$5.90
Volume
142.48K
Volume142.48K
52 Week high
$8.08
52 Week high$8.08
52 Week low
$2.51
52 Week low$2.51

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

STSA Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.